ARTICLE | Company News
Ariad gets orphan designation
February 24, 2000 8:00 AM UTC
ARIA received orphan drug designation for its AP1903 gene-targeted compound to treat acute graft-versus-host disease (GvHD). AP1903 is a small molecule used in ARIA's Ariad Regulated Gene Expression T...